核酸標記全球市場報告：趨勢、預測與競爭分析（至 2031 年）

全球核酸標記市場前景光明，醫院和診所市場以及診斷中心市場都存在機會。預計 2025 年至 2031 年期間全球核酸標記市場規模的複合年成長率為 7.7%。該市場的主要驅動力是對酵素和基因組研究的興趣日益濃厚、對個人化治療的需求不斷增加以及醫療保健成本不斷上升。

• Lucintel 表示，在標記類型類別中，生物素標記預計在預測期內將達到最高成長。
• 在最終用途類別中，診斷中心預計在預測期內將實現高速成長。
• 按地區分類，預計北美在預測期內將繼續佔據最大佔有率。

核酸標記市場的策略性成長機會

在生物技術進步和診斷解決方案需求不斷成長的推動下，核酸標記市場預計將經歷顯著成長。對於希望利用創新技術擴大市場佔有率的公司來說，策略機會正在出現。以下是這一不斷變化的情況下的五個關鍵成長機會。

• 擴展到新興市場：公司可以利用東南亞和非洲等新興市場對核酸標記解決方案日益成長的需求。這些地區不斷增加的研究舉措和不斷發展的醫療保健基礎設施對先進的診斷工具和標記技術產生了巨大的需求。
• 投資個人化醫療：個人化醫療趨勢為核酸標記公司提供了豐厚的機會。透過開發用於基因組分析和標靶治療的專用標記試劑，公司可以滿足精準醫療計劃的需求、改善患者治療效果並推動市場需求。
• 與生物製藥公司的合作：與生物製藥公司的策略夥伴關係推動核酸標記技術的創新。此次合作將促進先進的診斷和治療解決方案的開發，使我們能夠利用各自的專業知識來加速產品開發並提高市場競爭力。
• 利用人工智慧：將人工智慧 (AI) 融入核酸標記過程具有巨大的成長潛力。人工智慧增強了資料分析並最佳化了標記通訊協定，從而提高了準確性和效率。這種技術整合可以吸引尋求簡化工作流程和獲得更深入見解的研究機構。
• 強調永續實踐：隨著生物技術領域對永續性重視，開發環保標籤解決方案的機會也越來越多。投資綠色技術和永續材料有助於公司吸引具有環保意識的消費者，並順應全球負責任的實踐趨勢。

核酸標記市場提供了眾多策略性成長機會來推動創新和擴大市場範圍。透過專注於新興市場、個人化醫療、合作研究、人工智慧整合和永續性，公司可以在這個充滿活力和不斷發展的環境中取得成功。

核酸標記市場促進因素與挑戰

在技​​術進步和診斷解決方案需求不斷成長的推動下，核酸標記市場正在經歷顯著成長。儘管各種促進因素​​都在推動這一成長，但需要克服挑戰才能確保持續成長。了解這些因素對於在不斷變化的環境中的相關人員至關重要。以下是市場面臨的五個關鍵促進因素和三個挑戰：

核酸標記市場受以下因素驅動：

• 診斷需求不斷增加：遺傳疾病和感染疾病的盛行率不斷上升，推動了對有效診斷工具的需求。核酸標記在分子診斷中起著關鍵作用，可以準確檢測和量化核酸，改善患者護理和治療結果。
• 生物技術的進步：生物技術的快速進步，例如次世代定序(NGS) 和 CRISPR 技術，正在推動核酸標記市場的發展。這些技術需要先進的標記解決方案來提高靈敏度和特異性，從而刺激創新並吸引研發投資。
• 個人化醫療的成長：向個人化醫療的轉變對客製化診斷解決方案產生了強烈的需求。核酸標記對於基因組分析和標靶治療至關重要，使醫療保健專業人員能夠根據個人基因圖譜量身定做治療方案，並最終改善患者的治療效果。
• 政府舉措和資金：政府對生物技術研究和醫療保健舉措的津貼增加是核酸標記市場的主要驅動力。支持性政策和津貼鼓勵創新和發展，為企業擴大產品供應創造了良好的環境。
• 研究活動活性化：生命科學研究（尤其是基因組學和分子生物學）的投資不斷增加，推動了對核酸標記技術的需求。學術和研究機構正在積極尋求先進的標籤解決方案，以增強其實驗能力，進一步推動市場成長。

核酸標記市場面臨的挑戰是：

• 監管挑戰：對於核酸標記市場中的公司來說，遵循複雜的法律規範是一項重大挑戰。診斷工具和標記試劑的嚴格核准流程可能會延遲產品發布、阻礙創新並限制新興技術的市場進入。
• 競爭與市場飽和度：核酸標記市場競爭激烈，許多公司都在爭奪市場佔有率。這種飽和導致定價壓力和利潤率縮水，使得中小企業難以實現產品差異化並維持永續成長。
• 技術複雜性：核酸標記技術的快速進步給尋求保持競爭力的公司帶來了挑戰。跟上最新的技術創新並確保產品滿足不斷變化的客戶需求需要在研發方面進行大量投資，這對一些公司來說是一個障礙。

核酸標記市場受到多種因素的推動，包括診斷需求的不斷成長、生物技術的進步以及個人化醫療的興起。但要想在這種動態環境中取得成功，企業還必須應對監管複雜性和競爭加劇等挑戰。對於希望利用市場機會的相關人員來說，了解市場促進因素和挑戰至關重要。

目錄

第1章執行摘要

第2章全球核酸標記市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球核酸標記市場趨勢（2019-2024）及預測（2025-2031）
• 全球核酸標記市場（按標記類型）
  • 基於生物素
  • 螢光
  • 放射性
  • 其他
• 全球核酸標記市場（按應用）
  • 微陣列
  • DNA序列分析
  • 原位雜合反應
  • 聚合酵素鏈鎖反應
  • 其他
• 全球核酸標記市場（依最終用途）
  • 醫院和診所
  • 診斷中心
  • 其他

第4章各地區市場趨勢及預測分析（2019-2031）

• 全球核酸標記市場（按地區）
• 北美核酸標記市場
• 歐洲核酸標記市場
• 亞太核酸標記市場
• 世界其他地區核酸標記市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球核酸標記市場成長機會（按標記類型）
  • 全球核酸標記市場的成長機會（按應用）
  • 全球核酸標記市場成長機會（依最終用途分類）
  • 全球核酸標記市場各區域成長機會
• 全球核酸標記市場的新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球核酸標記市場的生產能力
  • 全球核酸標記市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業簡介

• Thermo Fisher Scientific
• New England Biolabs
• PerkinElmer
• F. Hoffmann La-Roche
• General Electric Company
• Merck
• Enzo Biochem
• Promega Corporation
• Vector Laboratories
• Agilent Technologies

The future of the global nucleic acid labeling market looks promising with opportunities in the hospital/clinic and diagnostic center markets. The global nucleic acid labeling market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are the growing interest in enzyme & genomic research, increasing requirements for customized treatment, and rising medical expenditures.

• Lucintel forecasts that, within the label type category, biotin-based is expected to witness the highest growth over the forecast period.
• Within the end-use category, diagnostic center is expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nucleic Acid Labeling Market

The nucleic acid labeling market is evolving rapidly, influenced by advancements in biotechnology and the growing demand for precision diagnostics. These trends are reshaping research methodologies and clinical applications, driving innovation in labeling techniques. Below are five key emerging trends that are making an impact in this field.

• Increased Automation: Automation is transforming nucleic acid labeling processes, enhancing efficiency and reducing human error. High-throughput systems enable researchers to perform large-scale experiments with consistent results, significantly expediting the workflow in genomics and diagnostics. This shift is particularly beneficial in clinical laboratories where time-sensitive results are crucial.
• Integration with Next-Generation Sequencing: The integration of nucleic acid labeling with next-generation sequencing (NGS) technologies is on the rise. Advanced labeling methods improve the accuracy and sensitivity of NGS applications, enabling comprehensive genomic analyses. This trend supports personalized medicine initiatives by allowing for more precise detection of genetic variations and mutations.
• Focus on Multiplexing: Multiplexing capabilities are becoming increasingly important in nucleic acid labeling. Researchers are seeking methods that allow simultaneous detection of multiple targets in a single assay, enhancing efficiency and cost-effectiveness. This trend is particularly beneficial for applications in diagnostics and disease monitoring, where rapid results are essential.
• Development of Novel Labels: The market is witnessing the emergence of innovative labeling agents, such as fluorescent dyes and nanoparticles. These novel labels offer improved sensitivity and stability compared to traditional options, facilitating better visualization and analysis of nucleic acids. Their versatility is expanding their use in a wide range of applications, including research, diagnostics, and therapeutics.
• Sustainability Initiatives: There is a growing emphasis on sustainability within the nucleic acid labeling market. Companies are increasingly developing eco-friendly labeling solutions that reduce waste and environmental impact. This trend reflects broader societal shifts toward sustainable practices in biotechnology and is attracting attention from environmentally conscious researchers and organizations.

The nucleic acid labeling market is experiencing transformative changes driven by automation, integration with advanced technologies, and a focus on sustainability. These trends not only enhance research capabilities but also pave the way for innovative diagnostic solutions, ultimately improving patient outcomes and advancing the field of biotechnology.

Recent Developments in the Nucleic Acid Labeling Market

The nucleic acid labeling market is rapidly evolving, marked by significant technological advancements and strategic collaborations. These developments are enhancing the capabilities of researchers and clinicians, paving the way for improved diagnostic tools and therapeutic applications. Below are five recent developments that are shaping the landscape of this dynamic market.

• Launch of Innovative Labeling Kits: Leading companies, such as Thermo Fisher Scientific, have introduced new labeling kits that enhance sensitivity and specificity in nucleic acid detection. These kits utilize cutting-edge technologies, enabling researchers to streamline their workflows and achieve more accurate results in both clinical and research settings.
• Advancements in CRISPR Technology: Recent breakthroughs in CRISPR technology have spurred demand for specialized nucleic acid labeling solutions. Companies are developing novel labels that facilitate precise gene editing and monitoring, thereby supporting advances in genomic research and therapeutic applications. This development is crucial for personalized medicine and targeted therapies.
• Collaborations in R&D: Increased partnerships between academic institutions and biotechnology firms are driving innovation in nucleic acid labeling. Collaborative efforts are focusing on developing advanced labeling techniques and improving existing methodologies. This trend is fostering knowledge exchange and accelerating the commercialization of new products that meet industry needs.
• Regulatory Approvals for Diagnostic Tools: Recent changes in regulatory frameworks have streamlined the approval processes for nucleic acid-based diagnostic tools. These changes facilitate faster market entry for innovative labeling technologies, promoting the development of rapid and reliable diagnostics. This is particularly important in response to global health challenges, such as pandemics.
• Emergence of Eco-Friendly Solutions: A growing number of companies are focusing on developing sustainable nucleic acid labeling products. Innovations in biodegradable materials and greener production processes are gaining traction, addressing environmental concerns in biotechnology. This shift towards sustainability is attracting interest from researchers and organizations committed to responsible practices.

Recent developments in the nucleic acid labeling market are driving significant progress across various sectors, from research to diagnostics. Innovations in technology, collaborations, and a focus on sustainability are shaping the future of this market, ultimately enhancing our understanding of genetics and improving healthcare outcomes.

Strategic Growth Opportunities for Nucleic Acid Labeling Market

The nucleic acid labeling market is poised for significant growth, driven by advancements in biotechnology and an increasing demand for diagnostic solutions. Strategic opportunities are emerging as organizations seek to leverage innovative technologies and expand their market presence. Here are five key growth opportunities in this evolving landscape.

• Expansion into Emerging Markets: Companies can capitalize on the growing demand for nucleic acid labeling solutions in emerging markets, such as Southeast Asia and Africa. These regions are experiencing a rise in research initiatives and healthcare infrastructure improvements, creating a significant need for advanced diagnostic tools and labeling technologies.
• Investment in Personalized Medicine: The trend toward personalized medicine presents a lucrative opportunity for nucleic acid labeling companies. By developing specialized labeling reagents tailored for genomic profiling and targeted therapies, organizations can meet the needs of precision medicine initiatives, enhancing patient outcomes and driving market demand.
• Collaboration with Biopharmaceutical Companies: Strategic partnerships with biopharmaceutical firms can enhance innovation in nucleic acid labeling technologies. Collaborations can lead to the development of advanced diagnostic and therapeutic solutions, leveraging each party's expertise to accelerate product development and improve market competitiveness.
• Utilization of Artificial Intelligence: Integrating artificial intelligence (AI) into nucleic acid labeling processes offers significant potential for growth. AI can enhance data analysis and optimize labeling protocols, leading to improved accuracy and efficiency. This technological integration can attract research institutions looking to streamline their workflows and gain deeper insights.
• Focus on Sustainable Practices: There is a growing emphasis on sustainability in the biotechnology sector, presenting an opportunity for companies to develop eco-friendly labeling solutions. By investing in green technologies and sustainable materials, organizations can appeal to environmentally conscious consumers and align with global trends toward responsible practices.

The nucleic acid labeling market is ripe with strategic growth opportunities that can drive innovation and expand market reach. By focusing on emerging markets, personalized medicine, collaborations, AI integration, and sustainability, companies can position themselves for success in this dynamic and evolving landscape.

Nucleic Acid Labeling Market Driver and Challenges

The nucleic acid labeling market is experiencing significant growth fueled by technological advancements and increasing demand for diagnostic solutions. Various drivers are propelling this growth, while challenges must be navigated to ensure sustained progress. Understanding these factors is crucial for stakeholders in this evolving landscape. Below are five key drivers and three challenges facing the market.

The factors responsible for driving the nucleic acid labeling market include:

• Increasing Demand for Diagnostics: The rising prevalence of genetic disorders and infectious diseases is driving demand for effective diagnostic tools. Nucleic acid labeling plays a critical role in molecular diagnostics, enabling accurate detection and quantification of nucleic acids, which enhances patient care and treatment outcomes.
• Advancements in Biotechnology: Rapid advancements in biotechnology, such as next-generation sequencing (NGS) and CRISPR technology, are propelling the nucleic acid labeling market. These technologies require sophisticated labeling solutions that improve sensitivity and specificity, driving innovation and attracting investment in research and development.
• Growth of Personalized Medicine: The shift towards personalized medicine is creating a strong demand for tailored diagnostic solutions. Nucleic acid labeling is essential for genomic profiling and targeted therapies, allowing healthcare providers to customize treatments based on individual genetic profiles, ultimately improving patient outcomes.
• Government Initiatives and Funding: Increased government funding for biotechnology research and healthcare initiatives is a significant driver in the nucleic acid labeling market. Supportive policies and grants encourage innovation and development, fostering a robust environment for companies to expand their product offerings.
• Rising Research Activities: Growing investment in life sciences research, particularly in genomics and molecular biology, is fueling demand for nucleic acid labeling technologies. Academic institutions and research organizations are actively seeking advanced labeling solutions to enhance their experimental capabilities, further driving market growth.

Challenges in the nucleic acid labeling market are:

• Regulatory Challenges: Navigating complex regulatory frameworks can pose significant challenges for companies in the nucleic acid labeling market. Stringent approval processes for diagnostic tools and labeling reagents may delay product launches, hindering innovation and limiting market access for emerging technologies.
• Competition and Market Saturation: The nucleic acid labeling market is becoming increasingly competitive, with numerous players vying for market share. This saturation can lead to pricing pressures and reduced profit margins, making it difficult for smaller companies to differentiate their offerings and maintain sustainable growth.
• Technological Complexity: The rapid pace of technological advancement in nucleic acid labeling presents challenges for companies seeking to stay competitive. Keeping up with the latest innovations and ensuring that products meet evolving customer needs requires significant investment in research and development, posing a barrier for some organizations.

The nucleic acid labeling market is driven by various factors, including growing demand for diagnostics, advancements in biotechnology, and the rise of personalized medicine. However, companies must also navigate challenges such as regulatory complexities and increased competition to thrive in this dynamic landscape. Understanding these drivers and challenges will be essential for stakeholders looking to capitalize on market opportunities.

List of Nucleic Acid Labeling Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nucleic acid labeling companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid labeling companies profiled in this report include-

• Thermo Fisher Scientific
• New England Biolabs
• PerkinElmer
• F. Hoffmann La-Roche
• General Electric Company
• Merck
• Enzo Biochem
• Promega Corporation
• Vector Laboratories
• Agilent Technologies

Nucleic Acid Labeling by Segment

The study includes a forecast for the global nucleic acid labeling market by label type, application, end use, and region.

Nucleic Acid Labeling Market by Label Type [Analysis by Value from 2019 to 2031]:

• Biotin-Based
• Fluorescent
• Radioactive
• Others

Nucleic Acid Labeling Market by Application [Analysis by Value from 2019 to 2031]:

• Microarray
• DNA Sequencing
• In Situ Hybridization
• Polymerase Chain Reaction
• Others

Nucleic Acid Labeling Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals/Clinics
• Diagnostic Centers
• Others

Nucleic Acid Labeling Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nucleic Acid Labeling Market

The nucleic acid labeling market has experienced significant growth and innovation, driven by advancements in biotechnology, increased research funding, and rising demand for diagnostics. Key players are focusing on developing more efficient labeling techniques and expanding their product offerings. This report highlights recent developments in the nucleic acid labeling market across the United States, China, Germany, India, and Japan, showcasing trends and emerging technologies that are shaping the landscape.

• United States: The U.S. market has seen increased investment in gene editing and diagnostics, with companies like Thermo Fisher Scientific launching new labeling kits. Advances in CRISPR technology have also propelled demand for nucleic acid labels in research and clinical applications.
• China: China is rapidly advancing its nucleic acid labeling capabilities, with a surge in domestic production and R&D initiatives. The government's support for biotechnology has led to collaborations between universities and industry, resulting in innovative labeling solutions and enhanced diagnostic tools.
• Germany: Germany continues to be a leader in precision biotechnology, with firms like Roche and Qiagen enhancing their nucleic acid labeling products. Recent regulatory changes are streamlining approval processes for new diagnostic tools, fostering innovation, and improving market access for advanced labeling techniques.
• India: The Indian nucleic acid labeling market is expanding due to a rise in molecular diagnostics and personalized medicine. Local startups are developing cost-effective labeling reagents, while partnerships with international firms are facilitating technology transfer and capacity building in the biotechnology sector.
• Japan: Japan is witnessing a surge in demand for nucleic acid labeling in genomics research, driven by advancements in next-generation sequencing technologies. Major companies are investing in developing innovative labeling solutions, with a focus on improving sensitivity and specificity in diagnostics and therapeutic applications.

Features of the Global Nucleic Acid Labeling Market

Market Size Estimates: Nucleic acid labeling market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nucleic acid labeling market size by label type, application, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid labeling market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different label types, applications, end uses, and regions for the nucleic acid labeling market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid labeling market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid labeling market by label type (biotin-based, fluorescent, radioactive, and others), application (microarray, DNA sequencing, in situ hybridization, polymerase chain reaction, and others), end use (hospitals/clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Labeling Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Nucleic Acid Labeling Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Nucleic Acid Labeling Market by Label Type
  • 3.3.1: Biotin-Based
  • 3.3.2: Fluorescent
  • 3.3.3: Radioactive
  • 3.3.4: Others
• 3.4: Global Nucleic Acid Labeling Market by Application
  • 3.4.1: Microarray
  • 3.4.2: DNA Sequencing
  • 3.4.3: In Situ Hybridization
  • 3.4.4: Polymerase Chain Reaction
  • 3.4.5: Others
• 3.5: Global Nucleic Acid Labeling Market by End Use
  • 3.5.1: Hospitals/Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Nucleic Acid Labeling Market by Region
• 4.2: North American Nucleic Acid Labeling Market
  • 4.2.1: North American Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.2.2: North American Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.3: European Nucleic Acid Labeling Market
  • 4.3.1: European Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.3.2: European Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.4: APAC Nucleic Acid Labeling Market
  • 4.4.1: APAC Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.4.2: APAC Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.5: ROW Nucleic Acid Labeling Market
  • 4.5.1: ROW Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.5.2: ROW Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nucleic Acid Labeling Market by Label Type
  • 6.1.2: Growth Opportunities for the Global Nucleic Acid Labeling Market by Application
  • 6.1.3: Growth Opportunities for the Global Nucleic Acid Labeling Market by End Use
  • 6.1.4: Growth Opportunities for the Global Nucleic Acid Labeling Market by Region
• 6.2: Emerging Trends in the Global Nucleic Acid Labeling Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nucleic Acid Labeling Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Labeling Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: New England Biolabs
• 7.3: PerkinElmer
• 7.4: F. Hoffmann La-Roche
• 7.5: General Electric Company
• 7.6: Merck
• 7.7: Enzo Biochem
• 7.8: Promega Corporation
• 7.9: Vector Laboratories
• 7.10: Agilent Technologies